**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 1073-67-2 |4-CHLOROSTYRENE, 98% (GC) | 98 | 214-028-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
The toxicological properties of this material have not been
investigated. Use appropriate procedures to prevent opportunities
for direct contact with the skin or eyes and to prevent inhalation.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids.
Skin:
Flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes.
Ingestion:
Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Clean up spills immediately,
observing precautions in the Protective Equipment section.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid
ingestion and inhalation.
Storage:
Store in a cool, dry place. Keep container closed when not in use.
Keep refrigerated. (Store below 4C/39F.)
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate general or local exhaust ventilation to keep airborne
concentrations below the permissible exposure limits. Use process
enclosure, local exhaust ventilation, or other engineering controls
to control airborne levels.
Exposure Limits
CAS# 1073-67-2:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149
approved full-facepiece airline respirator in the
positive pressure mode with emergency escape
provisions.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Not available.
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 73 deg C @ 14.00mm Hg
Freezing/Melting Point: 0 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.0870g/cm3
Molecular Formula: C8H7Cl
Molecular Weight: 138.60
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, light.
Incompatibilities with Other Materials:
Acids, bases, oxidizing agents, halogens.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1073-67-2: CZ0533000
LD50/LC50:
Not available.
Carcinogenicity:
4-CHLOROSTYRENE, 98% (GC) -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1073-67-2: No information available.
Canada
CAS# 1073-67-2 is listed on Canada's NDSL List.
CAS# 1073-67-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1073-67-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 10/01/1998 Revision #2 Date: 6/24/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
L-1-4'-Tosylamino-2-Phenylethyl Chloromethyl Ketone, 99+%
| 402-71-1 |
|
4-Methylumbelliferone phosphate, 99.5% (hplc)
| 3368-04-5 |
|
6-Chloro-meta-anisidine hydrochloride, 98%
| 2401-24-3 |
|
5-Indanol, 99%
| 1470-94-6 |
|
1,1-Dichloroethane,99+%, Stabilized with Nitromethane
| 75-34-3 |
|
2,3-Dihydro-2-Oxo-1H-Imidazol-4-Carbox-Aldehyde, 99%
| 0-00-1 |
|
2,5-Dihydroxy-1,4-Benzenedisulfonic Acid, Dipotassium Salt, 98%
| 15763-57-2 |
|
Phenacyltriphenylphosphonium bromide 96%
| 6048-29-9 |
|
cis-Pinonic acid, 98%
| 473-72-3 |
|
Camphene, 75%, Remainder Mainly Alpha-Fenchene
| 79-92-5 |
|
Scopolamine Hydrobromide Trihydrate, 99.0-101.0% (On The Anhydrous
| 6533-68-2 |
|
n-Methoxymethylaza-18-crown-6, 96%
| |
|
Benzyl Propionate, 98+%
| 122-63-4 |
|
1-Methyl-1-Phenylhydrazine, 98% (titr.)
| 618-40-6 |
|
O-(4-Nitrobenzyl)hydroxylamine hydrochloride, 98%
| 2086-26-2 |
|
alpha-Benzoin oxime, 98%
| 441-38-3 |
|
Oxalyl monoguanylhydrazide, 97% (titr.)
| 89797-67-1 |
|
3-Chlorobenzoic Acid, 98% (Titr.)
| 535-80-8 |
|
(R)-(+)-alpha-(1-Naphthyl)ethylamine 99+%
| 3886-70-2 |
|
Cyanocobalamin
| 68-19-9 |
|
Isopropan(ol-d), 98+ atom % d
| 3979-51-9 |
|
2-Bromostyrene, 98%, Stabilized With 0.005% 4-Tert.-Butylcatechol
| 2039-88-5 |
|
Methylamine-d5 deuteriochloride, 98+ atom % D
| 593-51-1 |
|
3,5-Dimethylphenol, 99+%
| 108-68-9 |
|
2-Chloro-5-nitrobenzonitrile, 99%
| 16588-02-6 |
|
6-Bromoveratraldehyde, 97%
| 5392-10-9 |
|
3,5-Dichlorobenzonitrile, 97%
| 6575-00-4 |
|
Methyl (R)-(-)-3-Hydroxybutyrate, 99%
| 3976-69-0 |
|
4-CHLOROSTYRENE, 98% (GC)
| 1073-67-2 |
|
Ethyl 2-hydroxyethyl sulfide, 98%
| 110-77-0 |
|
2-Bromobutane, 99+% (GC)
| 78-76-2 |
|
4-Bromo-2,2-Diphenylbutyronitrile, 95+%
| 39186-58-8 |
|
Acridine-4, 9-Dicarboxylic Acid Monohydrate
| 27574-29-4 |
|
N-Aminomorpholine, 97%(GC)
| 4319-49-7 |
|
Cyclohexyl Diphenyl Phosphine
| 6372-42-5 |
|
2,4-Diamino-6-Mercaptopyrimidine Hemisulfate, Tech.
| 81012-96-6 |
|
Diethyl Succinate, 99%
| 123-25-1 |
|
1,3-Difluoro-4-iodobenzene, 99+%
| 2265-93-2 |
|
Mono-methyl 5-nitroisophthalate, 98%
| 1955-46-0 |
|
Citric acid monohydrate
| 77-92-9 |
|
3-Pyrrolidino-1,2-Propanediol, 96%
| 85391-19-1 |
|
Delta-Valerolactam, 99%
| 675-20-7 |
|
Cycloheptyl Bromide, 97%
| 2404-35-5 |
|
Penicillin G Potassium Salt
| 113-98-4 |
|
Nicotinic acid hydrazide, 97%
| 553-53-7 |
|
Ethyl (2r,3r)-2,3-epoxy-3-methylpropanoate 96%
| 19780-35-9 |
|
Beta-Sitosterol, ca 75% Beta-Sitosterol, With ca 10% Campesterol
| |
|
3-Hydroxy-4(2-Hydroxy-4-Sulfo-1-Naphtyl Azo)naphthalene-2-Carboxylic
| 3737-95-9 |
|
Streptomycin sulfate
| 3810-74-0 |
|
Cyanogen Bromide
| 506-68-3 |
|
|